← Eichor
Study identifier: NCT05830669 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Remote Ischemic Preconditioning in Septic Patients

Condition: Critically Ill · Acute Kidney Injury · Sepsis  ·  Sponsor: Universität Münster

PhaseNA
Planned participants64
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Acute kidney injury is a well-recognized complication in critically ill patients. Up to date there is no clinically established method to reduce the incidence or the severity of acute kidney injury. Remote ischemic preconditioning (RIPC) will be induced by three cycles of upper limb ischemia. The aim of the study is to reduce the incidence of AKI by implementing remote ischemic preconditioning (identified by the urinary biomarkers tissue inhibitor of metalloproteinases-2 (TIMP-2) and insulin-like growth factor-binding protein 7(IGFBP7)

This description comes directly from the study's public registry record.

Talk to the study team

Melanie Meersch-Dini, MD  ·  +49-251-8347255  ·  meersch@uni-muenster.de

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospital Münster; Department of Anesthesiology, Intensive Care Medicine and Pain MedicineMünster, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05830669